Canada markets close in 2 hours 46 minutes

Greenwich LifeSciences, Inc. (GLSI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
15.86+0.20 (+1.31%)
As of 01:10PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 200.93M
Enterprise Value 195.42M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)39.24
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -21.23

Trading Information

Stock Price History

Beta (5Y Monthly) 3.33
52-Week Change 368.75%
S&P500 52-Week Change 323.63%
52 Week High 321.44
52 Week Low 37.58
50-Day Moving Average 314.86
200-Day Moving Average 312.46

Share Statistics

Avg Vol (3 month) 345.45k
Avg Vol (10 day) 334.01k
Shares Outstanding 512.88M
Implied Shares Outstanding 612.88M
Float 85.67M
% Held by Insiders 153.93%
% Held by Institutions 15.71%
Shares Short (Jun 28, 2024) 4260.17k
Short Ratio (Jun 28, 2024) 43.79
Short % of Float (Jun 28, 2024) 44.26%
Short % of Shares Outstanding (Jun 28, 2024) 42.02%
Shares Short (prior month May 31, 2024) 4195.09k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-69.02%
Return on Equity (ttm)-109.97%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -9.62M
Net Income Avi to Common (ttm)-9.24M
Diluted EPS (ttm)-0.71
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.51M
Total Cash Per Share (mrq)0.43
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)14.13
Book Value Per Share (mrq)0.40

Cash Flow Statement

Operating Cash Flow (ttm)-6.7M
Levered Free Cash Flow (ttm)-3.48M